Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Active, not recruiting	Phase 2	2025-07-23		NCT05894889

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cancer Institute and Hospital, Chinese Academy of Medical Sciences	294
Guangdong Provincial People's Hospital	164
Merck Sharp & Dohme LLC	650
Peking University	124
Shanghai Pulmonary Hospital, Shanghai, China	98

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Peking University	Beijing	China	3
Shanghai Pulmonary Hospital	Shanghai	China	23